Report Keyword:

China Marine Biological Medicine Industry Indepth Research and Investment Strategy Planning Report, 2013-2017

China Marine Biological Medicine Industry Indepth Research and Investment Strategy Planning Report, 2013-2017

Last Update:2014-05-23

Form of services:Book + (pdf or doc file) + CD

Send method:EMS 2-3 days for delivery

English Service:+86 0755 33220413

Chinese Service:+86 800-8306390 800-8306395

Report price:$7900   Print: $7800   CD: $7800

Online Consultation
Special statement:
Recently we find there are some sites steal report contents from who put those contents on their sites for sale by making a little changes about the contents or remaining the same which deceives buyers(e.g. unable to get full or correct reports, or main body differs from contents that announced on sites).Therefore, we recommend paying a visit to Qianzhan personally or by your friends, and make payment after confirmation. Special statement: Qianzhan is the only and right holder of all the research reports, and has never used a third party to sell any reports, please be aware of the trademark " " when purchasing. Qianzhan is the largest and strongest consultancy, who owns the greatest number of researchers. Here followed "Nine standards of companies' identificatios"。

This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.


Table of Content

China marine economy maintained the strong development momentum in the first decade of new century. The annual growth total output value of marine industry was 17.1% higher than the year-on-year increase of GDP. In the second decade of 21 century, with the support of national new strategy, China marine economy will enter a new development stage, and it’s expected to be a new growth spot and highlight of national economy.

Compared with traditional marine industries, emerging marine industry has great potential for development. So far, China has launched planning research works of marine strategic emerging industries, which provides new development opportunities for marine biological medicine industry.

In recent years, China marine biological technology research has extended from costal and epeiric sea to deep sea and polar. In particular, the discovery of marine bioactive compounds, the diversity research of metabolite structure in biological organism, the gene function and technology of marine organism, the marine medicine research and so on have aroused world’s great attention. Many research fruits have applied for domestic or international patent with independent intellectual property right. Marine medicine has extended from technology accumulation to product development stage. And it plays an important role in aspects of anti-AIDS, anti-tumor and health care.

At present, there are about 1,000 known medical marine organisms in China; by isolation, there are about 100 natural products; there are approximately 2,000 kinds of compound Chinese medicine. And there are about 10 kinds of marine medicine having been approved by the State to list; about 10 kinds of marine products have won the title of “health”.

After many years of research, it’s reported there are 230 kinds of known algae, which contain multivitamin and pharmacological effects, and there are 246 kinds of known algae, which contain anti-cancer substance.

Marine biological medicine industry has been listed in the seven marine strategic emerging industries, which has emerged as a focus of China hi-tech field and marine economy, extending from technology accumulation to the industry development stage. According to incomplete statistics, there have already been about 10 marine biological medicine research institutions as well as hundreds of the development and production enterprises. From 2001 to 2010, the annual growth of China marine biological medicine industry value-added increased by 24.7%. It’s predicted the value-added will achieve more than 80 billion Yuan.

The marine biological medicine industry ushers in a good momentum of development, however, due to the limitations of marine development technology and marine biological medicine technology, the potential pharmaceutical value of many marine natural products have yet been unknown to us. Meanwhile, because of the complex production process and long period of research and development, testing, clinical stages, the industry size is still small and it will face a series of problems, such as the loose combination of industry, study and research, the backward intellectual property right and so on, which are all needed to deal with gradually. Therefore, China marine biological medicine industry still has the space for further development.

With the upsurge of blue economy, many coastal areas in Shandong, Guangdong, Jiangsu, Fujian and other areas gradually increase the investment in marine biological medicine industry, regarding it as a new point of economic growth to advance the development of blue economy. By tackling key problems in science and technology, Shandong Zhongda Bio-pharmaceutical has successfully extracted a kind of anti-AIDS medicine——F-skin care. Guangdong marine biological medicine industry develops earlier and walks in front of the whole country. A ground of well-known enterprises represented by Guangdong Antaeus Group and Growful gradually enter into the marine biological medicine industry. Jiangsu province established the first provincial marine medicine research and development center in 1997. Since then, it has listed the marine medicine as a priority to develop marine emerging industries. Currently, the breakthrough has been made for instance, Jiangsu Shuanglin Marine Biological Pharmaceutical company has earned great economic benefits after introducing the new self-made healthcare products with the functions of lowering blood sugar, handover, and calcium supplement. The emerging marine industries have huge investment opportunities. In the future, the study of marine biological medicine will focus on 9 drug fields, such as marine anti-cancer drugs, marine cardiovascular drugs and marine drugs of digestive system. And the six aspects of fiscal and tax policies, finance policies, government procurement policies, digest, absorption and re-innovation policies, as well as innovation base and platform policies will gain national support. According to prediction, the proportion of China strategic marine emerging industries in marine total output value is expected to increase by 13%-15%, with an average increase not less than 20%; then marine biological medicine industry has the most prospects for development.

Here, we would like to express our sincere gratitude to State Information Center, Bureau of Statistics of China, China Customs, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!

Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!

Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Marine Biological Medicine Industry


China Marine Biological Medicine Industry Report" related reports »

Purchase Mode:

1. English Service:  +86 0755 33220413

2. Chinese Service:  +86 8008306390 8008306395

3. Mail Order:

4. Online Order:  Click "Order Now" button on this page

5. Purchase On-site:  19F Block A, First World Plaza, Hongli West Rd, Futian District, Shenzhen China

Warm tips:
  • 1. Please be aware of " Qianzhan " trademark, qianzhan has never used any third to sell reports, please make a phone call and purchase it directly.
  • 2. You are warmly welcome to visit Qianzhan, and close transaction after confirmation.
Industry Research
·Energy and Environment»
New Energy Natural Gas Energy Conservation Water Resources Coal Electricity Others
·Recreation and Sports»
Education Advertisement Film and Television Publication Packing and Printing Sports Resort Hotel Catering Internet Animation Others Media
·Financial Services»
Banking Insurance Securities Leasing Credit Others
·Transport Logistics and Supporting»
Water Transport Airport Road Transport Logistic Distribution Vehicle and Fittings Post-Market Others
·Medical and Health»
Medical Device Biomedicine Medical Institution Healthcare and Nursing Medicine and Pharmacy Others
·Retail or FMCG»
Retail Commercial Trade Food Beverage Dairy Product Seasoning Wine and Tobacco Cosmetics Cleaning Product Daily Necessities Others
·Real Estate and Construction»
Real Estate Real Estate Intermediary Public Safety Construction Engineering Survey and Design Building Materials Housing Accomodation Others
·Mechanical Manufacturing»
Precision Instrument Transport Instrument Electricity Supporting Equipment Special Equipment General Equipment Others
·New Chemical Material»
Ink and Pigment Coating Chemical Fibres Synthetic Fibres Chemicals Industrial Chemicals Rubber Plastics Basic Chemicals Others
·Light Textile and Clothing»
Luxury Jewelry Leather Raw Materials Shoes and Hats Clothing Textile Others
·Household Appliance and IT»
White Goods Optic Instrument Electrical Component Semiconductor Brown Goods Small Appliances Communication IT Consumer Electronics Others
·Minerals and Metallurgy»
Metal Product Metallurgy Non-Ferrous Metal Steel Mining Industry Others
Copyright Notice

1. The copyright of this report is reserved by Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan), the shipment and post-sale service is handled by the issue department of Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan). The only copyright of all research report products of our company is reserved; we did not authorize any third party sales agent, if you are to purchase our report, please contact our customer service directly.

2. A limited of customers are offered with our reports with compensation; those reports are only for internal usage and are only for researching and analyzing purposes. We will not be responsible for any misunderstanding or legal issues caused by external usage or references with the report.

Beginner's Guide
Order Reference
Delivery & Payment
Sale protection
Service Hotline
  • Order Hotline:+86 800-830-6390
  • Customer service:
    +86 800-830-6395
    +86 400-068-7188